- Home
- EDIT vs PMM Comparison
EDIT vs PMM Comparison
Compare EDIT & PMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDIT
- PMM
- Stock Information
- Founded
- EDIT 2013
- PMM 1989
- Country
- EDIT United States
- PMM United States
- Employees
- EDIT N/A
- PMM N/A
- Industry
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- PMM Investment Managers
- Sector
- EDIT Health Care
- PMM Finance
- Exchange
- EDIT Nasdaq
- PMM Nasdaq
- Market Cap
- EDIT 263.7M
- PMM 252.3M
- IPO Year
- EDIT 2016
- PMM N/A
- Fundamental
- Price
- EDIT $2.28
- PMM $5.86
- Analyst Decision
- EDIT Buy
- PMM
- Analyst Count
- EDIT 12
- PMM 0
- Target Price
- EDIT $6.20
- PMM N/A
- AVG Volume (30 Days)
- EDIT 2.2M
- PMM 118.3K
- Earning Date
- EDIT 08-19-2025
- PMM 01-01-0001
- Dividend Yield
- EDIT N/A
- PMM 4.68%
- EPS Growth
- EDIT N/A
- PMM N/A
- EPS
- EDIT N/A
- PMM 0.23
- Revenue
- EDIT $35,837,000.00
- PMM N/A
- Revenue This Year
- EDIT N/A
- PMM N/A
- Revenue Next Year
- EDIT N/A
- PMM N/A
- P/E Ratio
- EDIT N/A
- PMM $26.52
- Revenue Growth
- EDIT N/A
- PMM N/A
- 52 Week Low
- EDIT $0.91
- PMM $5.00
- 52 Week High
- EDIT $4.90
- PMM $6.42
- Technical
- Relative Strength Index (RSI)
- EDIT 43.28
- PMM 51.94
- Support Level
- EDIT $2.37
- PMM $5.84
- Resistance Level
- EDIT $2.67
- PMM $5.86
- Average True Range (ATR)
- EDIT 0.23
- PMM 0.04
- MACD
- EDIT -0.08
- PMM 0.01
- Stochastic Oscillator
- EDIT 5.37
- PMM 95.83
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.
About PMM Putnam Managed Municipal Income Trust
Putnam Managed Municipal Income Trust is a closed-end management investment company. Its investment objective is to seek a high level of current income exempt from federal income tax by investing in a diversified portfolio of tax-exempt municipal securities. The Fund invests in various sectors such as healthcare, retirement community, private higher education, housing-backed, essential service utilities, and state-backed bonds.